What is the appropriate emergency management for an allergic reaction (anaphylaxis) in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Emergency Management of Anaphylaxis in Adults

Immediately administer intramuscular epinephrine 0.3-0.5 mg (1:1000 dilution) into the mid-outer thigh as soon as anaphylaxis is recognized—this is the only evidence-based, life-saving intervention and should never be delayed. 1

Immediate First-Line Treatment

Epinephrine Administration

  • Route: Intramuscular (IM) into the vastus lateralis (mid-outer thigh) is the preferred initial route due to rapid absorption, effectiveness, and safety 1, 2
  • Dose: 0.3-0.5 mg of 1:1000 (1 mg/mL) solution for adults 1
  • Repeat dosing: Give every 5-15 minutes as needed if symptoms persist or recur 1, 2
  • No absolute contraindications exist—the risk of death from anaphylaxis outweighs any theoretical concerns about epinephrine side effects, even in patients with cardiovascular disease 3

Intravenous Epinephrine (Special Circumstances Only)

Use IV epinephrine only when:

  • Patient is in cardiac arrest, OR
  • Profound hypotension unresponsive to IM epinephrine and IV fluids 4
  • IV dose: 0.05-0.1 mg (50-100 mcg) of 1:10,000 solution, given slowly 1
  • Infusion: 5-15 mcg/min, titrated to effect for refractory cases 3, 1
  • Requires continuous hemodynamic monitoring 4

Concurrent Essential Interventions

Airway, Breathing, Circulation

  1. Position: Place patient supine with legs elevated (unless respiratory distress/vomiting present) 5, 2
  2. Oxygen: Administer 100% high-flow oxygen immediately 3
  3. Airway management: Prepare for rapid advanced airway intervention—laryngeal edema can develop quickly and may require emergency cricothyroidotomy 1
  4. Call for help: Activate emergency response/resuscitation team 5

Fluid Resuscitation

  • Indication: Any patient with hypotension, orthostasis, or incomplete response to IM epinephrine 3
  • Rationale: Up to 35% of intravascular volume can shift to extravascular space within minutes 3
  • Treatment: Large-volume normal saline or lactated Ringer's solution via large-bore IV 4, 5
  • Start immediately—do not wait to see if epinephrine alone works 3

Second-Line Adjunctive Therapies

These medications have slow onset (4-6 hours) and should never delay or substitute for epinephrine 3, 6:

H1 Antihistamines

  • Diphenhydramine 25-50 mg IV/IM 4, 3
  • Only relieves urticaria and itching—does NOT treat airway, breathing, or circulatory problems 3
  • Consider less-sedating alternatives (cetirizine 10 mg) post-stabilization 3

H2 Antihistamines

  • Ranitidine 1 mg/kg IV (diluted in D5W, given over 5 minutes) 4
  • Combination H1+H2 is superior to H1 alone, but evidence remains limited 4

Corticosteroids

  • Methylprednisolone 1-2 mg/kg/day IV (or equivalent) 4
  • NOT helpful acutely—onset 4-6 hours 3
  • May prevent biphasic reactions (occur in up to 20% of cases within 3 days) 3
  • Consider for: severe/prolonged anaphylaxis, history of asthma, or idiopathic anaphylaxis 4

Bronchodilators

  • Nebulized albuterol 2.5-5 mg for bronchospasm resistant to epinephrine 4, 3
  • Adjunctive only—does not replace epinephrine 3

Refractory Anaphylaxis Management

Vasopressors

  • Indication: Persistent hypotension despite epinephrine and IV fluids 3
  • Dopamine 2-20 mcg/kg/min titrated to blood pressure 4
  • Requires continuous hemodynamic monitoring and ICU transfer 3

Glucagon (β-Blocker Patients)

  • Critical for patients on β-blockers who may be resistant to epinephrine 3
  • Dose: 1-5 mg IV over 5 minutes, followed by infusion 5-15 mcg/min 3
  • Warning: Can cause vomiting—aspiration precautions needed 4, 3

Atropine

  • Consider for bradycardia 3

Observation and Monitoring

  • Minimum observation: 4-6 hours for most patients 3
  • Prolonged observation/admission: Required for severe reactions, multiple epinephrine doses, or refractory symptoms 3
  • Biphasic reaction risk factors: Severe initial presentation, need for >1 epinephrine dose 6
  • All biphasic reactions occur within 3 days 3

Critical Diagnostic Testing

Serum Tryptase

Obtain three samples 5:

  1. First: As soon as feasible after resuscitation starts (do not delay treatment)
  2. Second: 1-2 hours after symptom onset
  3. Third: 24 hours or at follow-up (baseline level)

Discharge Requirements

Every patient must receive 3, 2:

  • Two epinephrine auto-injectors with hands-on training
  • Written anaphylaxis emergency action plan
  • Medical identification jewelry or wallet card
  • Mandatory allergist/immunologist referral 4, 3

Post-Discharge Medications (2-3 days)

  • H1 antihistamine (diphenhydramine every 6 hours or non-sedating alternative)
  • H2 antihistamine (ranitidine twice daily)
  • Oral corticosteroid (prednisone 0.5 mg/kg daily) 3

Common Pitfalls to Avoid

  1. Delaying epinephrine while giving antihistamines/steroids first—this is the most dangerous error 1, 6
  2. Using IV epinephrine inappropriately in non-arrest situations without monitoring 4
  3. Subcutaneous epinephrine—absorption is unreliable; always use IM route 1, 2
  4. Allowing patient to stand/walk—can precipitate cardiovascular collapse 2
  5. Inadequate fluid resuscitation in hypotensive patients 3
  6. Discharging without epinephrine auto-injector prescription and training 3
  7. Failing to obtain tryptase levels for diagnostic confirmation 5

Cardiac Arrest from Anaphylaxis

  • Standard CPR and ACLS protocols 1
  • High-dose IV epinephrine: 1-3 mg (1:10,000) over 3 minutes, then 3-5 mg, then 4-10 mg/min infusion 4
  • Prolonged resuscitation efforts are more likely successful in anaphylaxis 4
  • Aggressive volume expansion 4

The evidence consistently demonstrates that prompt IM epinephrine is the only intervention proven to reduce mortality in anaphylaxis—all other treatments are supportive adjuncts that should never delay this life-saving medication. 1, 6

Related Questions

What are the recommended guidelines for the acute management of anaphylaxis and its underlying IgE‑mediated pathophysiology?
What is the emergency management for an allergic reaction causing acute desaturation?
What is the appropriate emergency management for an anaphylactoid reaction in adults and children?
What is the appropriate emergency management for a 19-year-old male who was stung by a honey bee and subsequently vomited 8–10 times, with abdominal pain and anxiety?
What is the appropriate acute management and follow‑up for a 22‑year‑old male who, 2 hours after an unknown allergen exposure, presents with a 1 mm wheal on the right upper inner lip, mild associated swelling and throbbing, mild tongue and throat itching, stable vital signs, and who declines immediate epinephrine?
When should an adult with LDL‑C ≥190 mg/dL, premature atherosclerotic cardiovascular disease, or a first‑degree relative with early coronary disease or familial hypercholesterolemia undergo a comprehensive genetic lipid panel, and which genes should be sequenced?
What is the appropriate management of chronic hypertension in a 27-year-old woman at 12 weeks gestation on labetalol with a blood pressure of 159/91 mm Hg?
What is the appropriate treatment for acute frontal sinusitis with fever lasting three days?
What are the anesthetic considerations and management plan for a patient with severe aortic stenosis undergoing abdominal surgery?
Given complement C3 176 mg/dL, complement C4 36 mg/dL, negative anti‑Ro, anti‑Sm, and anti‑dsDNA antibodies, erythrocyte sedimentation rate 18 mm/hr, C‑reactive protein 3 mg/L, and treatment with amlodipine 10 mg for hypertension, could these findings be due to Cushing’s syndrome?
In a child with no significant clinical changes over the past five months, is an adrenal tumor less likely?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.